220 related articles for article (PubMed ID: 25333471)
1. Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning--a word of caution.
Helgeland E; Breivik LE; Vaudel M; Svendsen ØS; Garberg H; Nordrehaug JE; Berven FS; Jonassen AK
PLoS One; 2014; 9(10):e109279. PubMed ID: 25333471
[TBL] [Abstract][Full Text] [Related]
2. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review.
Tapuria N; Kumar Y; Habib MM; Abu Amara M; Seifalian AM; Davidson BR
J Surg Res; 2008 Dec; 150(2):304-30. PubMed ID: 19040966
[TBL] [Abstract][Full Text] [Related]
3. The release of cardioprotective humoral factors after remote ischemic preconditioning in humans is age- and sex-dependent.
Heinen A; Behmenburg F; Aytulun A; Dierkes M; Zerbin L; Kaisers W; Schaefer M; Meyer-Treschan T; Feit S; Bauer I; Hollmann MW; Huhn R
J Transl Med; 2018 Apr; 16(1):112. PubMed ID: 29703217
[TBL] [Abstract][Full Text] [Related]
4. Modifications in rat plasma proteome after remote ischemic preconditioning (RIPC) stimulus: identification by a SELDI-TOF-MS approach.
Hibert P; Prunier-Mirebeau D; Beseme O; Chwastyniak M; Tamareille S; Pinet F; Prunier F
PLoS One; 2014; 9(1):e85669. PubMed ID: 24454915
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection by Humoral Factors Released After Remote Ischemic Preconditioning Depends on Anesthetic Regimen.
Bunte S; Behmenburg F; Eckelskemper F; Mohr F; Stroethoff M; Raupach A; Heinen A; Hollmann MW; Huhn R
Crit Care Med; 2019 Mar; 47(3):e250-e255. PubMed ID: 30608281
[TBL] [Abstract][Full Text] [Related]
6. Remote ischemic preconditioning (RIPC) modifies plasma proteome in humans.
Hepponstall M; Ignjatovic V; Binos S; Monagle P; Jones B; Cheung MH; d'Udekem Y; Konstantinov IE
PLoS One; 2012; 7(11):e48284. PubMed ID: 23139772
[TBL] [Abstract][Full Text] [Related]
7. Profiling of cell stress protein expression in cardiac tissue of cardiosurgical patients undergoing remote ischemic preconditioning: implications for thioredoxin in cardioprotection.
Zitta K; Meybohm P; Gruenewald M; Cremer J; Zacharowski KD; Scholz J; Steinfath M; Albrecht M
J Transl Med; 2015 Jan; 13():34. PubMed ID: 25622749
[TBL] [Abstract][Full Text] [Related]
8. Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways.
Skyschally A; Gent S; Amanakis G; Schulte C; Kleinbongard P; Heusch G
Circ Res; 2015 Jul; 117(3):279-88. PubMed ID: 26058828
[TBL] [Abstract][Full Text] [Related]
9. Repeated Episodes of Remote Ischemic Preconditioning for the Prevention of Myocardial Injury in Vascular Surgery.
Thomas KN; Cotter JD; Williams MJ; van Rij AM
Vasc Endovascular Surg; 2016 Apr; 50(3):140-6. PubMed ID: 27075990
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning.
Hibert P; Prunier-Mirebeau D; Beseme O; Chwastyniak M; Tamareille S; Lamon D; Furber A; Pinet F; Prunier F
PLoS One; 2013; 8(10):e77211. PubMed ID: 24155931
[TBL] [Abstract][Full Text] [Related]
11. The timing of propofol administration affects the effectiveness of remote ischemic preconditioning induced cardioprotection in rats.
Chen K; Yu J; Wang Q; Wu L; Liu X; Wong GTC; Lu Y
J Cell Biochem; 2020 Nov; 121(11):4535-4541. PubMed ID: 32030809
[TBL] [Abstract][Full Text] [Related]
12. Effects of ischemic preconditioning protocols on skeletal muscle ischemia-reperfusion injury.
Kocman EA; Ozatik O; Sahin A; Guney T; Kose AA; Dag I; Alatas O; Cetin C
J Surg Res; 2015 Feb; 193(2):942-52. PubMed ID: 25438960
[TBL] [Abstract][Full Text] [Related]
13. Remote Ischemic Preconditioning Decreases the Magnitude of Hepatic Ischemia-Reperfusion Injury on a Swine Model of Supraceliac Aortic Cross-Clamping.
Martikos G; Kapelouzou A; Peroulis M; Paspala A; Athanasiadis D; Machairas A; Liakakos T; Moulakakis K; Vasdekis S; Lazaris AM
Ann Vasc Surg; 2018 Apr; 48():241-250. PubMed ID: 28887256
[TBL] [Abstract][Full Text] [Related]
14. Review of remote ischemic preconditioning: from laboratory studies to clinical trials.
Anttila V; Haapanen H; Yannopoulos F; Herajärvi J; Anttila T; Juvonen T
Scand Cardiovasc J; 2016; 50(5-6):355-361. PubMed ID: 27595164
[TBL] [Abstract][Full Text] [Related]
15. Effects of remote ischemic preconditioning and myocardial ischemia on microRNA-1 expression in the rat heart in vivo.
Brandenburger T; Grievink H; Heinen N; Barthel F; Huhn R; Stachuletz F; Kohns M; Pannen B; Bauer I
Shock; 2014 Sep; 42(3):234-8. PubMed ID: 24978894
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats.
Singh A; Randhawa PK; Bali A; Singh N; Jaggi AS
Cardiovasc Drugs Ther; 2017 Apr; 31(2):133-143. PubMed ID: 28194544
[TBL] [Abstract][Full Text] [Related]
17. Late Phases of Cardioprotection During Remote Ischemic Preconditioning and Adenosine Preconditioning Involve Activation of Neurogenic Pathway.
Singh H; Kumar M; Singh N; Jaggi AS
J Cardiovasc Pharmacol; 2019 Feb; 73(2):63-69. PubMed ID: 30422893
[TBL] [Abstract][Full Text] [Related]
18. Influence of Hyperglycemia and Diabetes on Cardioprotection by Humoral Factors Released after Remote Ischemic Preconditioning (RIPC).
Torregroza C; Gnaegy L; Raupach A; Stroethoff M; Feige K; Heinen A; Hollmann MW; Huhn R
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445586
[TBL] [Abstract][Full Text] [Related]
19. Remote Ischemic Preconditioning Does Not Affect the Release of Humoral Factors in Propofol-Anesthetized Cardiac Surgery Patients: A Secondary Analysis of the RIPHeart Study.
Ney J; Hoffmann K; Meybohm P; Goetzenich A; Kraemer S; Benstöm C; Weber NC; Bickenbach J; Rossaint R; Marx G; Zacharowski K; Bernhagen J; Stoppe C
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621201
[TBL] [Abstract][Full Text] [Related]
20. Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection.
Billah M; Ridiandries A; Allahwala U; Mudaliar H; Dona A; Hunyor S; Khachigian LM; Bhindi R
Oncotarget; 2019 Jan; 10(2):216-244. PubMed ID: 30719216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
